Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,325
Closed -$240K 1650
2025
Q2
$240K Sell
2,325
-535
-19% -$51K ﹤0.01% 1431
2025
Q1
$265K Sell
2,860
-8,978
-76% -$877K ﹤0.01% 1331
2024
Q4
$1.11M Sell
11,838
-5,184
-30% -$502K 0.02% 747
2024
Q3
$1.67M Buy
17,022
+126
+0.7% +$11.7K 0.03% 612
2024
Q2
$1.65M Sell
16,896
-1,026
-6% -$114K 0.03% 593
2024
Q1
$2.2M Buy
17,922
+7,316
+69% +$852K 0.04% 488
2023
Q4
$1.29M Buy
10,606
+2,883
+37% +$337K 0.02% 628
2023
Q3
$913K Buy
7,723
+4,026
+109% +$511K 0.02% 702
2023
Q2
$486K Sell
3,697
-2,081
-36% -$258K 0.01% 986
2023
Q1
$781K Buy
5,778
+250
+5% +$33.8K 0.02% 782
2022
Q4
$767K Buy
5,528
+2,358
+74% +$291K 0.02% 768
2022
Q3
$305K Sell
3,170
-50
-2% -$5.21K 0.01% 1060
2022
Q2
$318K Buy
3,220
+200
+7% +$24.9K 0.01% 1084
2022
Q1
$441K Sell
3,020
-25,072
-89% -$3.17M 0.01% 1056
2021
Q4
$3.26M Buy
28,092
+8,627
+44% +$1.05M 0.06% 376
2021
Q3
$2.38M Buy
19,465
+15,456
+386% +$2.02M 0.04% 451
2021
Q2
$523K Buy
4,009
+128
+3% +$18K 0.01% 1016
2021
Q1
$558K Buy
+3,881
New +$484K 0.01% 918
2014
Q1
Sell
-5,131
Closed -$304K 1402
2013
Q4
$304K Sell
5,131
-1,775
-26% -$106K 0.01% 1007
2013
Q3
$417K Buy
+6,906
New +$391K 0.01% 828

Other funds holding AGCO

Oppenheimer & Co's AGCO Position: Q3 2025 in Review

Oppenheimer & Co sold out of AGCO (AGCO) in Q3 2025, closing a stake of 2,325 shares — an estimated $240K sold.

Oppenheimer & Co first reported a position in AGCO in Q3 2013 and held it in 20 quarters. The position peaked at $3.26M in Q4 2021. 454 funds tracked by Wall St. Rank hold AGCO as of Q3 2025.

  • Oppenheimer & Co reported no remaining AGCO position as of Q3 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 2,325 AGCO shares in Q3 2025, an estimated $240K.
  • Oppenheimer & Co first reported a position in AGCO in Q3 2013 and held it in 20 quarters.
  • Oppenheimer & Co's AGCO position peaked at $3.26M in Q4 2021.
  • 454 funds tracked by Wall St. Rank held AGCO as of Q3 2025.

Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.